08
May

MorphoSys pulled the trigger on a deal for partner Lanthio Pharma, paying €20 million ($22 million) for the shares it didn’t already own and picking up a handful of peptide candidates.

…read more

Source: MorphoSys bags a peptide biotech for $22M

    

0 No comments